Empagliflozin as a potential therapy for PCOS: Restoring hormonal balance and ovarian function in a letrozole-induced rat model

This publication has 82 references indexed in Scilit:

• Molecular mechanism of empagliflozin cardioprotection in 5-fluorouracil (5-FU)-induced cardiotoxicity via modulation of SGLT2 and TNFα/TLR/NF-κB signaling pathway in rats
  Toxicological Research, 2023
• Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Preserved Trial
  European Journal of Heart Failure, 2023
• Effect of sodium–glucose cotransporter 2 inhibitors on insulin resistance; a systematic review and meta-analysis
  Acta Diabetologica, 2022
• Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality
  Journal of Assisted Reproduction and Genetics, 2020
• Empagliflozin suppresses inflammation and protects against acute septic renal injury
  Inflammopharmacology, 2020
• Activation of TGF‐β1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells
  Journal of Cellular Physiology, 2018
• Activity of LPO Processes in Women with Polycystic Ovarian Syndrome and Infertility
  Bulletin of Experimental Biology and Medicine, 2017
• Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease
  Archives of Medical Research, 2004
• Defining the actions of transforming growth factor beta in reproduction
  BioEssays, 2002
• Determination of malonaldehyde precursor in tissues by thiobarbituric acid test
  Analytical Biochemistry, 1978